These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3563969)

  • 1. Role of red blood cells in the early stages of platelet activation by collagen.
    Santos MT; Vallés J; Aznar J; Pérez-Requejo JL
    Thromb Haemost; 1986 Dec; 56(3):376-81. PubMed ID: 3563969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early platelet-collagen interactions in whole blood and their modifications by aspirin and dipyridamole evaluated by a new method (BASIC wave).
    Pérez-Requejo JL; Aznar J; Santos MT; Vallés J
    Thromb Haemost; 1985 Dec; 54(4):799-803. PubMed ID: 4089814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Erythrocytes modulate the anti-aggregation effect of aspirin and dipyridamole. Study under static conditions and in a flow system].
    Bozzo J; Hernández MR; Ordinas A
    Sangre (Barc); 1996 Feb; 41(1):13-8. PubMed ID: 8779028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biphasic initial phase of platelet aggregation inhibition after oral aspirin.
    Walter E; Zimmermann R; Siess R; Staiger C; Weber E
    Artery; 1980; 8(5):501-6. PubMed ID: 7213053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable platelet response to aspirin in patients with ischemic stroke.
    Hohlfeld T; Weber AA; Junghans U; Schumacher M; Boucher M; Schrör K; Siebler M
    Cerebrovasc Dis; 2007; 24(1):43-50. PubMed ID: 17519543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virgin olive oil polyphenol hydroxytyrosol acetate inhibits in vitro platelet aggregation in human whole blood: comparison with hydroxytyrosol and acetylsalicylic acid.
    Correa JA; López-Villodres JA; Asensi R; Espartero JL; Rodríguez-Gutiérez G; De La Cruz JP
    Br J Nutr; 2009 Apr; 101(8):1157-64. PubMed ID: 18775097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The variability of platelet-collagen interaction. Its influence on aspirin-induced inhibition of platelet aggregation.
    Sack ES; Quiroga E
    Thromb Haemost; 1976 Jun; 35(3):658-68. PubMed ID: 989971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent inhibition of human platelet aggregation by prasugrel and its interaction with aspirin in healthy subjects.
    Jakubowski JA; Payne CD; Weerakkody GJ; Brandt JT; Farid NA; Li YG; Naganuma H; Lachno DR; Winters KJ
    J Cardiovasc Pharmacol; 2007 Mar; 49(3):167-73. PubMed ID: 17414229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of acetylsalicylic acid on human platelet function in vivo at salicylate steady state.
    Simrock R; Missalla A; Schwidtal P; Lischke V; Breddin HK
    Thromb Haemost; 1984 Apr; 51(2):269-71. PubMed ID: 6740559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of acetylsalicylic acid on platelet aggregation and capillary bleeding in healthy cats].
    Hart S; Deniz A; Sommer B; Kietzmann M; Nolte I
    Dtsch Tierarztl Wochenschr; 1995 Dec; 102(12):476-80. PubMed ID: 8591748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of association between aspirin responsiveness and seven candidate gene haplotypes in patients with symptomatic vascular disease.
    Kunicki TJ; Williams SA; Nugent DJ; Harrison P; Segal HC; Syed A; Rothwell PM
    Thromb Haemost; 2009 Jan; 101(1):123-33. PubMed ID: 19132198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
    Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow- and lesion-dependent thrombosis in the porcine ex vivo model.
    Vilahur G; Segalés E; Salas E; Badimon L
    Circulation; 2004 Sep; 110(12):1686-93. PubMed ID: 15381660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin therapy for inhibition of platelet reactivity in the presence of erythrocytes in patients with vascular disease.
    Santos MT; Vallés J; Aznar J; Lago A; Sanchez E; Cosin J; Moscardó A; Piñón M; Broekman MJ; Marcus AJ
    J Lab Clin Med; 2006 May; 147(5):220-7. PubMed ID: 16697769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acetylsalicylic acid (ASA) resistance in patients with ischemic heart disease (IHD) as bioindicator of the treatment strategy].
    Malý J; Pecka M; Gregor J; Dulícek P; Blazek M; Malý R; Pudil R; Bláha M
    Cas Lek Cesk; 2005; 144 Suppl 3():23-9. PubMed ID: 16335259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual platelet thromboxane A2 and prothrombotic effects of erythrocytes are important determinants of aspirin resistance in patients with vascular disease.
    Santos MT; Valles J; Lago A; Tembl J; Sánchez E; Moscardo A; Cosin J
    J Thromb Haemost; 2008 Apr; 6(4):615-21. PubMed ID: 18221358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prostacyclin-sparing effect of indobufen vs. aspirin.
    De Caterina R; Giannessi D; Bernini W; Lazzerini G; Lavezzari M; Stragliotto E; Biagi G; Coccheri S
    Thromb Haemost; 1996 Mar; 75(3):510-4. PubMed ID: 8701417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macroaggregation of platelets in plasma, as distinct from microaggregation in whole blood (and plasma), as determined using optical aggregometry and platelet counting respectively, is specifically impaired following cardiopulmonary bypass in man.
    Menys VC; Belcher PR; Noble MI; Evans RD; Drossos GE; Pillai R; Westaby S
    Thromb Haemost; 1994 Oct; 72(4):511-8. PubMed ID: 7533335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial inhibition of platelet thromboxane A2 synthesis by aspirin is associated with myonecrosis in patients with ST-segment elevation myocardial infarction.
    Valles J; Santos MT; Fuset MP; Moscardo A; Ruano M; Perez F; Piñon M; Breña S; Aznar J
    Am J Cardiol; 2007 Jan; 99(1):19-25. PubMed ID: 17196455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.